27 gennaio 2009 / 23:35 / 9 anni fa

UPDATE 1-Genzyme buys some assets, 3 mln shrs of Exact Sciences

Jan 27 (Reuters) - Exact Sciences (EXAS.O), which develops technologies that detect cancer, said Genzyme Corp GENZ.O bought certain assets related to prenatal and reproductive health and 3 million of its shares, in a deal that will see Exact receive $24.5 million in cash.

Genzyme purchased the shares at $2 per share for an aggregate purchase price of $6 million. The per-share offer price is 34 percent more than Exact’s closing price of $1.49 Tuesday on Nasdaq.

In trading after the bell, shares of Exact were up 23 percent at $1.83.

Earlier this month, Sequenom Inc SQNM.O made an offer to Exact shareholders to buy the company for about $41 million, two days after its bid was rejected by Exact’s board. (Reporting by Anand Basu in Bangalore; Editing by Pratish Narayanan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below